L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition-Reference-Cited by-同舟云学术

L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition

Published:2007-06 Issue:12 Volume:73 Page:1971-1981
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Huang Z.,Dias R.,Jones T.,Liu S.,Styhler A.,Claveau D.,Otu F.,Ng K.,Laliberte F.,Zhang L.,Goetghebeur P.,Abraham W.M.,Macdonald D.,Dubé D.,Gallant M.,Lacombe P.,Girard Y.,Young R.N.,Turner M.J.,Nicholson D.W.,Mancini J.A.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference38 articles.

1. Beta-adrenoceptors on smooth muscle, nerves and inflammatory cells;Barnes;Life Sci,1993

2. Adenylyl cyclases and the interaction between calcium and cAMP signalling;Cooper;Nature,1995

3. Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases;Iyengar;FASEB J,1993

4. Complexity and diversity of mammalian adenylyl cyclases;Sunahara;Annu Rev Pharmacol Toxicol,1996

5. Mammalian membrane-bound adenylyl cyclases;Taussig;J Biol Chem,1995

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of PDE4 Inhibitor-Induced Hypothermia as a Correlate of Nausea in Mice;Biology;2021-12-20

2. The Molecular Biology of Phosphodiesterase 4 Enzymes as Pharmacological Targets: An Interplay of Isoforms, Conformational States, and Inhibitors;Pharmacological Reviews;2021-07

3. Diabetic Theory in Anti-Alzheimer’s Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors;Current Medicinal Chemistry;2021-06-10

4. Roflumilast: A potential drug for the treatment of cognitive impairment?;Neuroscience Letters;2020-09

5. Phosphodiesterase inhibitors say NO to Alzheimer's disease;Food and Chemical Toxicology;2019-12